AbCellera Biologics Inc.ABCLNASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank86
3Y CAGR+73.7%
5Y CAGR-61.9%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+73.7%/yr
Annual compound
5Y CAGR
-61.9%/yr
Recent acceleration
Percentile
P86
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 31.03% |
| 2024 | -32.70% |
| 2023 | -209.56% |
| 2022 | 5.92% |
| 2021 | 31.01% |
| 2020 | 3889.92% |
| 2019 | -446.75% |
| 2018 | 0.00% |